AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2024
Feb 8, 2024
29809_dirs_2024-02-08_626b646b-90e1-448b-b818-6987ee2438ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2024-02-07
Reporting Person: Rosa David J. (President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-07 | Common Stock | M | 22050 | $59.2278 | Acquired | 176299 | Direct |
| 2024-02-07 | Common Stock | S | 12900 | $389.2867 | Disposed | 163399 | Direct |
| 2024-02-07 | Common Stock | M | 22050 | $57.1111 | Acquired | 185449 | Direct |
| 2024-02-07 | Common Stock | S | 12840 | $389.3041 | Disposed | 172609 | Direct |
| 2024-02-07 | Common Stock | M | 28125 | $51.0156 | Acquired | 200734 | Direct |
| 2024-02-07 | Common Stock | S | 16150 | $389.2276 | Disposed | 184584 | Direct |
| 2024-02-07 | Common Stock | M | 40500 | $49.0889 | Acquired | 225084 | Direct |
| 2024-02-07 | Common Stock | S | 23120 | $389.2818 | Disposed | 201964 | Direct |
| 2024-02-07 | Common Stock | M | 28125 | $49.3433 | Acquired | 230089 | Direct |
| 2024-02-07 | Common Stock | S | 15700 | $389.2856 | Disposed | 214389 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | Non-Qualified Stock Option (right to buy) | $49.0889 | M | 40500 | Disposed | 2024-08-07 | Common Stock (40500) | Direct |
| 2024-02-07 | Non-Qualified Stock Option (right to buy) | $49.3433 | M | 28125 | Disposed | 2024-02-18 | Common Stock (28125) | Direct |
| 2024-02-07 | Non-Qualified Stock Option (right to buy) | $51.0156 | M | 28125 | Disposed | 2024-08-15 | Common Stock (28125) | Direct |
| 2024-02-07 | Non-Qualified Stock Option (right to buy) | $57.1111 | M | 22050 | Disposed | 2025-02-17 | Common Stock (22050) | Direct |
| 2024-02-07 | Non-Qualified Stock Option (right to buy) | $59.2278 | M | 22050 | Disposed | 2025-08-17 | Common Stock (22050) | Direct |
Footnotes
F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2025.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,000 shares sold at $386.61 to $387.54; 2,050 shares sold at $387.70 to $388.67; 6,109 shares sold at $388.80 to $389.76; 3,201 shares sold at $389.84 to $390.61; and 540 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,100 shares sold at $386.61 to $387.54; 1,900 shares sold at $387.70 to $388.67; 5,974 shares sold at $388.80 to $389.75; 3,526 shares sold at $389.84 to $390.79; and 340 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57 as follows: 1,712 shares sold at $386.61 to $387.37; 2,350 shares sold at $387.70 to $388.42; 7,354 shares sold at $388.80 to $389.77; 4,094 shares sold at $389.84 to $390.73; and 640 shares sold at $390.91 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $392.00 as follows: 2,057 shares sold at $386.61 to $387.37; 3,377 shares sold at $387.70 to $388.69; 10,942 shares sold at $388.77 to $389.77; 5,904 shares sold at $389.79 to $390.79; 740 shares sold at $390.91 to $391.57; and 100 shares sold at $392.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $386.61 to $391.57as follows: 1,300 shares sold at $386.61 to $387.54; 2,400 shares sold at $387.70 to $388.67; 7,622 shares sold at $388.77 to $389.75; 3,938 shares sold at $389.84 to $390.79; and 440 shares sold at $390.96 to $391.57. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F8: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.